Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Clinical trial NCT03480230 · UNKNOWN

Trial details

NCT number: NCT03480230
Sponsor: Arafat Tfayli
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Stage

Start date: 2018-06-26
Primary completion: 2022-11-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.